Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTEM
4201
DELISTED
Molecular Templates, Inc.
MTEM
| $66.4K | ﹤0.01% |
47,231
+5,240
| +12% | +$7.28K |
|
4202
FingerMotion
FNGR
$18.1M
| $66.1K | ﹤0.01% |
30,327
| – | – |
|
4203
Nocera
NCRA
$3.07M
| $65.9K | ﹤0.01% |
1,893
+217
| +13% | +$6.5K |
|
|
RPTX
4204
DELISTED
Repare Therapeutics
RPTX
| $65.8K | ﹤0.01% |
19,128
-7,416
| -28% | -$24.4K |
|
4205
GlucoTrack
GCTK
$3.34M
| $65.5K | ﹤0.01% |
+23
| New | +$55.9K |
|
|
RGF
4206
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
| $65.1K | ﹤0.01% |
13,571
+495
| +4% | +$2.7K |
|
4207
Inhibikase Therapeutics
IKT
$388M
| $65.1K | ﹤0.01% |
50,065
+12,735
| +34% | +$17K |
|
|
AMLI
4208
DELISTED
American Lithium Corp. Common Stock
AMLI
| $64.8K | ﹤0.01% |
115,650
| – | – |
|
|
LUXH
4209
DELISTED
LuxUrban Hotels Inc. Common Stock
LUXH
| $64.8K | ﹤0.01% |
10,999
+8,714
| +381% | +$70.4K |
|
|
VSEE
4210
VSEE HEALTH INC
VSEE
| $64.5K | ﹤0.01% |
+43,304
| New | +$139K |
|
4211
MIND Technology
MIND
$46.2M
| $64K | ﹤0.01% |
16,697
+2,448
| +17% | +$10.3K |
|
|
PROC
4212
DELISTED
Procaps Group, S.A. Ordinary Shares
PROC
| $64K | ﹤0.01% |
28,938
| – | – |
|
|
VIVS
4213
VivoSim Labs
VIVS
$1.64M
| $63.9K | ﹤0.01% |
10,457
+1,260
| +14% | +$8.77K |
|
4214
Tenax Therapeutics
TENX
$503M
| $63.6K | ﹤0.01% |
18,390
+7,349
| +67% | +$26.6K |
|
4215
Pulmatrix
PULM
$6.06M
| $63.3K | ﹤0.01% |
29,581
+3,108
| +12% | +$6.52K |
|
4216
EUDA Health Holdings
EUDA
$47.6M
| $63.2K | ﹤0.01% |
802
| – | – |
|
4217
Allot
ALLT
$383M
| $63.1K | ﹤0.01% |
21,262
| – | – |
|
4218
OneMedNet
ONMD
$35.6M
| $62.5K | ﹤0.01% |
102,247
-83,188
| -45% | -$80.4K |
|
4219
Oramed Pharmaceuticals
ORMP
$179M
| $62.1K | ﹤0.01% |
25,455
| – | – |
|
4220
Moleculin Biotech
MBRX
$2.89M
| $62K | ﹤0.01% |
873
+83
| +11% | +$5.98K |
|
4221
Senti Biosciences Holdings
SNTI
$11M
| $61.7K | ﹤0.01% |
27,293
+2,734
| +11% | +$7.22K |
|
4222
MMTec
MTC
$299M
| $61.3K | ﹤0.01% |
14,821
+2,855
| +24% | +$7.22K |
|
4223
Innoviz Technologies
INVZ
$112M
| $61.2K | ﹤0.01% |
73,873
-196,747
| -73% | -$150K |
|
|
NIXX
4224
Nixxy Inc
NIXX
$16.1M
| $61.1K | ﹤0.01% |
22,291
+9,152
| +70% | +$19.5K |
|
|
QTI
4225
QT Imaging Holdings
QTI
$37.6M
| $60.6K | ﹤0.01% |
85,455
+6,717
| +9% | +$4.19K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.